Kathryn C. Elliott - Concepedia

Author

Kathryn C. Elliott

Also Known As

Elliott, Kathryn, K Elliott, K. Elliott, Kathryn C. Elliott, Kathryn Elliott

Publications

706

Citations

H-Index

Concepts

All Affiliations

Kathryn C. Elliott is an author at University of California San Diego specializing in tumor biology, medicine, and pathology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	535
2	Pathology	2	2	172
3	Pharmacology	2	2	172
4	Health Sciences	1	1	363
5	Cell Biology	1	1	363

Kathryn C. Elliott

Publications

706

Citations

H-Index

Page 1

	Year	Citations
An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition Laetitia Seguin, Shumei Kato, Aleksandra Franovic, Nature Cell Biology Tumor BiologyIntegrin β3–Kras–ralbEgfr InhibitionMedicineStem Cells	2014	363
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Cancer Cell Neuro-oncologyMedicineDruggable VulnerabilityPathologyCancer Genomics	2017	160
Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers Laetitia Seguin, Maria F. Camargo, Hiromi I. Wettersten, Cancer Discovery	2017	101
Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence Aleksandra Franovic, Kathryn C. Elliott, Laetitia Seguin, Cancer Research	2015	39
Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription Huawei Wang, John D. Lapek, Ken Fujimura, Cell Discovery	2018	31
Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Annals of Oncology Neuro-oncologyMedicineDruggable VulnerabilityPathologyCancer Genomics	2017	12

Page 1